Drug: Trastuzumab Injury: Ejection fraction decreased Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 91787862 | Trastuzumab | Ejection fraction decreased | ROCHE | 0.00 | F | 0 | 20160810 | GB |
| 115970302 | Trastuzumab | Ejection fraction decreased | ROCHE | 72.85 YR | F | 0 | 20160824 | GB |
| 119654222 | Trastuzumab | Ejection fraction decreased | ROCHE | 0.00 | 0 | 20160901 | FR | |
| 125398671 | TRASTUZUMAB | Ejection fraction decreased | NOVARTIS | 44.79 YR | F | 67 KG | 20160708 | IE |
| 126468761 | Trastuzumab | Ejection fraction decreased | ROCHE | 0.00 | F | 0 | 20160812 | IT |
| 127361381 | Trastuzumab | Ejection fraction decreased | ROCHE | 0.00 | F | 0 | 20160913 | CA |
Total Records: 6 Number of Pages: 1